Evidence map›Paper›PMID 32269965›Full record

ArticleFrontiers in oncology2020

Editorial: Precision/Personalized Pediatric Oncology and Immune Therapies: Rather Customize Than Randomize.

Michal Kýr, Giannoula Lakka Klement, Lenka Zdrazilova-Dubska, Regina Demlova, Dalibor Valik, Ondrej Slaby, Irene Slavc, Jaroslav Sterba

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Michal KýrDepartment of Pediatric Oncology, University Hospital Brno, Brno, Czechia.
Giannoula Lakka KlementDepartment of Pediatric Oncology, University Hospital Brno, Brno, Czechia.
Lenka Zdrazilova-DubskaDepartment of Laboratory Medicine, Masaryk Memorial Cancer Institute, Brno, Czechia.
Regina DemlovaDepartment of Pharmacology, Faculty of Medicine, Masaryk University, Brno, Czechia.
Dalibor ValikDepartment of Pediatric Oncology, University Hospital Brno, Brno, Czechia.
Ondrej SlabyDepartment of Pathology, University Hospital Brno, Brno, Czechia.
Irene SlavcDepartment of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria.
Jaroslav SterbaDepartment of Pediatric Oncology, University Hospital Brno, Brno, Czechia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

clinical trial designsdrug modelspediatric oncologypersonalized medicinepersonalized precision pediatric oncologyprecision oncologytrial models

Identifiers

PMID32269965
PMCPMC7109439

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.